Abstract:Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making. Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making.

Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny

A Single-Cell Hematopoietic Landscape Resolves 8 Lineage Trajectories and Defects in Kit Mutant Mice.

Embryonic lineage tracing with Procr-CreER marks balanced hematopoietic stem cell fate during entire mouse lifespan

Inactivation of a single copy of Crebbp selectively alters pre-mRNA processing in mouse hematopoietic stem cells

Lineage Marker Synchrony in Hematopoietic Genealogies Refutes the PU.1/GATA1 Toggle Switch Paradigm

From Hematopoietic Stem Cells to Platelets: Unifying Differentiation Pathways Identified by Lineage Tracing Mouse Models

Myeloid Lineage Choice is Not Controlled by the Pu.1-Gata1 Switch

Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

Hlf Expression Marks Early Emergence of Hematopoietic Stem Cell Precursors With Adult Repopulating Potential and Fate

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Hemopoietic lineage commitment decisions: in vivo evidence from a transgenic mouse model harboring micro LCR-betapro-LacZ as a transgene

A subset of megakaryocytes regulates development of hematopoietic stem cell precursors

Neuropilin-2 genomic elements drive cre recombinase expression in primitive blood, vascular and neuronal lineages

Early Myeloid Lineage Choice is Not Initiated by Random PU.1 to GATA1 Protein Ratios

Clonal analysis of fetal hematopoietic stem/progenitor cell subsets reveals how post-transplantation capabilities are distributed

Identification and Isolation of Hematopoietic Stem Cells and Progenitors with Discrete Developmental Gene Expression Programs

Non-hierarchically related HSCs replenish platelets by distinct progenitor pathways

Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line

Redefining hematopoietic progenitor cells and reforming the hierarchy of hematopoiesis

Genetic lineage tracing of resident stem cells by DeaLT

Revisiting the lineage contribution of hematopoietic stem and progenitor cells